Vonapanitase

N/A

Report date: 2024/05/01 20:00:37

Base Information

Drug NameVonapanitase
Drug Alias Namevonapanitase沃那尼他酶vonapanitasa伏纳胰弹性酶伏帕尼酶 +[8] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionExtracellular matrix protein modulators
TargetsExtracellular matrix protein
Therapy Area/IndicationsPeripheral Arterial DiseaseRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProteon Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProteon Therapeutics
Active IndicationsN/A
Inactive IndicationsPeripheral Arterial DiseaseRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A